VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with Technical Breakout Potential
By Mill Chart
Last update: Jun 6, 2025
VERICEL CORP (NASDAQ:VCEL) was identified by our screener as a strong growth stock exhibiting a promising technical setup. The company, specializing in advanced therapies for sports medicine and severe burn care, combines solid growth fundamentals with a developing technical pattern that could signal an upward move.
Growth Fundamentals
- Revenue Growth: VCEL has demonstrated strong revenue expansion, with a 14.81% increase over the past year and a 15.01% annualized growth rate over multiple years. Future revenue is projected to grow by 24.77% yearly.
- Earnings Momentum: Earnings per share (EPS) surged by 400% in the last year, with an expected annual growth of 72.04% in the coming years.
- Profitability: The company maintains a healthy gross margin of 72.54%, outperforming 83.15% of its biotechnology peers.
Financial Health
- Balance Sheet Strength: VCEL has no debt and a strong current ratio of 5.01, indicating solid liquidity.
- Solvency: The Altman-Z score of 9.81 suggests low bankruptcy risk, ranking better than 86.74% of industry competitors.
Technical Setup
- Consolidation Pattern: VCEL has been trading in a range between $38.62 and $44.41, currently near the upper boundary. A breakout above $43.41 could signal further upside.
- Support Levels: Multiple support zones exist between $37.91 and $42.05, providing a cushion against downward moves.
- Setup Rating: The stock earns a technical setup score of 7/10, suggesting a potential entry point if resistance is breached.
While VCEL’s valuation appears high with a P/E of 1,446.67, its growth trajectory and niche market position in biotechnology justify investor interest.
For more details, review the full fundamental analysis of VCEL or check the technical report.
Our Strong Growth Stocks with Good Technical Setup Ratings screener lists more stocks with similar characteristics.
Disclaimer
This is not investment advice. Always conduct your own research before making financial decisions.
